Effect of Preoperative Oral Carbohydrates on the Insulin Resistance of Elderly Patients

May 24, 2021 updated by: Yonsei University
Postoperative cognitive dysfunction (POCD) is more common in older patients, and increased insulin resistance is an important factor for POCD. Fasting before surgery is performed to reduce the incidence of pulmonary aspiration after anesthesia. However, prolonged fasting increases insulin resistance. Recently, it is recommended to minimize fasting times and consume carbohydrate drinks before surgery. Therefore, the investigators investigate whether preoperative carbohydrate drinks can reduce insulin resistance in the elderly patients. Fifty patients (age>65 years) scheduled for arthroplasty will be divided into carbohydrate (n=28) and control (n=28) groups. Randomly selected patients of the carbohydrate group are given 400ml of 12.8 g/100 ml carbohydrate beverage 2-3 hours before their scheduled operation. In contrast, patients in the control group are fasted from water 2 h before surgery according to standard protocol.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of
        • Department of Anesthesiology and Pain Medicine , Anesthesia and Pain Research Institute, Yonsei University College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients undergoing arthroplasty
  2. age>65 years

Exclusion Criteria:

  1. The subject is a foreigner or illiterate
  2. Patients with gastroesophageal reflux disease, gastric emptying disorders, inflammatory bowel disease, or previous treatment for intra-abdominal cancer
  3. Patients with chronic renal disease or severe cardiovascular disease
  4. HbA1c >69 mmol/mol or BMI >30 kg/m2
  5. A duration of ≥5 h between consumption of CHO and initiation of surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Active Comparator: Carbohydrate group
Randomly selected patients of the carbohydrate group are given oral carbohydrate (400ml) 2-3 hours before surgery. In contrast, patients in the control group are fasted water 2 hours before surgery according to the standard protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insulin resistance
Time Frame: Before anesthesia
Insulin resistance index = glucose x insulin/22.5
Before anesthesia
Insulin resistance
Time Frame: 1 hour after surgery
Insulin resistance index = glucose x insulin/22.5
1 hour after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
glycemic variability
Time Frame: Before anesthesia
Coefficient of glucose variability =SD/mean x 100 (%)
Before anesthesia
glycemic variability
Time Frame: 5 minutes after anesthesia
Coefficient of glucose variability =SD/mean x 100 (%)
5 minutes after anesthesia
glycemic variability
Time Frame: 1 hour after surgery
Coefficient of glucose variability =SD/mean x 100 (%)
1 hour after surgery
glycemic variability
Time Frame: 10 minutes after admission of recovery room
Coefficient of glucose variability =SD/mean x 100 (%)
10 minutes after admission of recovery room

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2020

Primary Completion (Actual)

January 13, 2021

Study Completion (Actual)

January 18, 2021

Study Registration Dates

First Submitted

December 15, 2019

First Submitted That Met QC Criteria

December 19, 2019

First Posted (Actual)

December 20, 2019

Study Record Updates

Last Update Posted (Actual)

May 25, 2021

Last Update Submitted That Met QC Criteria

May 24, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 4-2019-1014

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Old Age

Clinical Trials on carbohydrate group - carbohydrate (400ml)

Subscribe